- Home
- APRE vs IDAI Comparison
APRE vs IDAI Comparison
Compare APRE & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- IDAI
- Stock Information
- Founded
- APRE 2006
- IDAI 2016
- Country
- APRE United States
- IDAI United States
- Employees
- APRE N/A
- IDAI N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- IDAI Computer Software: Prepackaged Software
- Sector
- APRE Health Care
- IDAI Technology
- Exchange
- APRE Nasdaq
- IDAI Nasdaq
- Market Cap
- APRE 9.4M
- IDAI 7.7M
- IPO Year
- APRE 2019
- IDAI N/A
- Fundamental
- Price
- APRE $1.55
- IDAI $2.98
- Analyst Decision
- APRE Strong Buy
- IDAI
- Analyst Count
- APRE 1
- IDAI 0
- Target Price
- APRE $20.00
- IDAI N/A
- AVG Volume (30 Days)
- APRE 33.0K
- IDAI 23.5K
- Earning Date
- APRE 11-06-2025
- IDAI 08-14-2025
- Dividend Yield
- APRE N/A
- IDAI N/A
- EPS Growth
- APRE N/A
- IDAI N/A
- EPS
- APRE N/A
- IDAI N/A
- Revenue
- APRE $841,012.00
- IDAI $3,366,415.00
- Revenue This Year
- APRE N/A
- IDAI $25.13
- Revenue Next Year
- APRE N/A
- IDAI $48.09
- P/E Ratio
- APRE N/A
- IDAI N/A
- Revenue Growth
- APRE N/A
- IDAI N/A
- 52 Week Low
- APRE $1.41
- IDAI $1.43
- 52 Week High
- APRE $5.01
- IDAI $18.75
- Technical
- Relative Strength Index (RSI)
- APRE 42.03
- IDAI 54.65
- Support Level
- APRE $1.49
- IDAI $2.71
- Resistance Level
- APRE $1.65
- IDAI $3.08
- Average True Range (ATR)
- APRE 0.08
- IDAI 0.17
- MACD
- APRE -0.01
- IDAI 0.01
- Stochastic Oscillator
- APRE 23.08
- IDAI 73.96
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.